Influential Panel Gives Thumbs Down To Routine Prostate Cancer Test

Routine testing of men's blood to detect prostate cancer is unwarranted, and causes more harm than good, according to findings of the U.S. Preventive Services Task Force. The panel of experts sets the agenda for doctors and, increasingly, insurance payments.